Related Experiment Videos
Lymphoproliferative disorder after liver transplantation
1Department of Surgery, Chang Gung College of Medicine and Technology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Taiwan.
Summary
Pediatric liver transplant recipients can develop fatal lymphoproliferative disorders (LPD), often linked to Epstein-Barr virus (EBV). Early detection and avoiding excessive immunosuppression are crucial for managing this complication.
Area of Science:
- Pediatric Oncology
- Transplantation Immunology
- Virology
Background:
- Lymphoproliferative disorder (LPD) is a serious complication following solid organ transplantation.
- Epstein-Barr virus (EBV) infection is strongly associated with post-transplant LPD.
- Immunosuppression is a key factor contributing to LPD development.
Observation:
- A 2.5-year-old boy developed EBV-associated LPD manifesting as small bowel lymphoma after liver transplantation.
- The patient experienced intermittent fever and documented EBV reactivation post-transplant.
- Abdominal pain and peritonitis led to the discovery of multiple small bowel perforations due to B cell lymphoma.
Findings:
- The pediatric patient succumbed to multiple organ failure despite treatment and cessation of immunosuppressive agents.
- The case highlights a fatal outcome of LPD in a young liver transplant recipient.
- B cell lymphoma was identified as the cause of small bowel perforations.
Implications:
- Preventing over-immunosuppression in pediatric liver transplant recipients is critical.
- Early diagnosis and prompt treatment of LPD are essential to improve survival rates.
- This case underscores the need for vigilant monitoring for LPD in immunocompromised pediatric patients.